- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/712 - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Patent holdings for IPC class A61K 31/712
Total number of patents in this class: 1785
10-year publication summary
|
76
|
81
|
86
|
94
|
114
|
120
|
126
|
142
|
151
|
105
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 888 |
124 |
| Alnylam Pharmaceuticals, Inc. | 1143 |
46 |
| F. Hoffmann-La Roche AG | 7948 |
32 |
| Hoffmann-La Roche Inc. | 3478 |
31 |
| Nippon Shinyaku Co., Ltd. | 324 |
26 |
| Wave Life Sciences Ltd. | 174 |
26 |
| Osaka University | 3397 |
25 |
| Sarepta Therapeutics, Inc. | 382 |
25 |
| University of Massachusetts | 2232 |
25 |
| Roche Innovation Center Copenhagen A/S | 135 |
23 |
| Avidity Biosciences, Inc. | 160 |
23 |
| Arrowhead Pharmaceuticals, Inc. | 310 |
17 |
| Isis Pharmaceuticals, Inc. | 209 |
17 |
| The Regents of the University of California | 20108 |
16 |
| National Center of Neurology and Psychiatry | 149 |
15 |
| Dyne Therapeutics, Inc. | 251 |
15 |
| Centre National de La Recherche Scientifique | 10564 |
14 |
| CuRNA, Inc. | 131 |
13 |
| Daiichi Sankyo Company, Limited | 1877 |
13 |
| ProQR Therapeutics II B.V. | 115 |
13 |
| Other owners | 1246 |